MustGrow Biologics Corp. Announces Results of Shareholder Meeting

Executive Summary

• MustGrow Biologics Corp. held its 2026 annual meeting of shareholders on June 25, 2026, to vote on director elections, auditor re-appointment, and an amended equity incentive plan.
• All seven director nominees were elected by shareholders with overwhelming approval rates ranging from 98.70% to 99.76%.
• Shareholders approved the re-appointment of Ernst & Young LLP as auditors and approved the amended and restated omnibus equity incentive plan, which remains subject to final TSXV approval.

Key Details

• Director Elections: All nominees were elected via ballot: Corey Giasson, Colin Bletsky, Brad Munro, Thomas Flow, Matt Kowalski, David Borecky, and Laura Westby.
• Voting Results: Votes "For" ranged from 5,293,453 (98.70%) to 5,350,353 (99.76%), with minimal "Withheld" votes across all nominees.
• Auditor Re-appointment: Ernst & Young LLP, Chartered Professional Accountants, was re-appointed as the Company's auditors, with directors authorized to fix their remuneration.
• Omnibus Equity Incentive Plan: The amended and restated omnibus equity incentive plan was approved by shareholders and is now pending final approval from the TSX Venture Exchange.
• Regulatory Filing: A formal report on the voting results for all matters voted upon will be filed on SEDAR+ under the Company's profile.

Notable Quotes

• (No quotes provided in the release.)